Efficacy of the Laparoendoscopic “Rendezvous” to Treat Cholecystocholedocholithiasis in 210 Consecutive Patients: A Single Center Experience

    loading  Checking for direct PDF access through Ovid

Abstract

Objective:

The simultaneous laparoendoscopic “rendezvous” (LERV) represents an alternative to sequential or totally laparoscopic approaches for patients affected by cholecystocholedocholithiasis. The aim of this study was to analyze the results in a large series of 210 consecutive patients.

Materials and Methods:

From 2002 to 2016 all patients affected by cholecystocholedocholithiasis were treated with a standardized “tailored” LERV. The relevant technical features of the procedure were recorded. An analysis of feasibility, effectiveness in stone clearance, and safety was performed.

Results:

Among 214 patients with common bile duct stones, 210 were treated with LERV and 4 with open rendezvous approach. Intraoperative cholangiography confirmed common bile duct stones in 179 patients (85.2%) or sludge in 18 (8.5%) and in 98.9% stone clearance was obtained endoscopically. Endoscopic papilla cannulation was feasible in 161 patients (76.7%), whereas in 49 (23.3%) a transcystic guidewire was needed. The overall LERV feasibility was 96.6%. The conversion rate to open surgery was 3.3%. Minor morbidity was observed in 1.9% of cases, mortality in 0.47%, and the mean hospital stay was 4.3 days.

Conclusions:

These results confirm the high effectiveness of LERV. This approach to treat cholecystocholedocholithiasis should be preferred and therefore implemented where a strong collaboration between surgeons and endoscopists is possible.

Related Topics

    loading  Loading Related Articles